HighTower Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185K	Buy	19,399 +1,369	+8%	+$10.6K	﹤0.01%	3511
2025 Q4	$141K	Buy	18,030 +930	+5%	+$6.72K	﹤0.01%	3455
2025 Q3	$130K	Buy	17,100 +100	+0.6%	+$833	﹤0.01%	3490
2025 Q2	$152K	Sell	17,000 -61	-0.4%	-$568	﹤0.01%	3382
2025 Q1	$128K	Sell	17,061 -539	-3%	-$4.35K	﹤0.01%	3309
2024 Q4	$132K	Sell	17,600 -1,459	-8%	-$11.1K	﹤0.01%	3310
2024 Q3	$146K	Sell	19,059 -1,091	-5%	-$8.29K	﹤0.01%	3223
2024 Q2	$124K	Buy	20,150 +2,000	+11%	+$11K	﹤0.01%	3154
2024 Q1	$92K	Hold	18,150	–	–	﹤0.01%	3166
2023 Q4	$109K	Buy	18,150 +201	+1%	+$1.17K	﹤0.01%	3178
2023 Q3	$126K	Sell	17,949 -651	-4%	-$4.68K	﹤0.01%	3043
2023 Q2	$131K	Buy	+18,600	New	+$149K	﹤0.01%	3009
2021 Q1	–	Sell	-25,726	Closed	-$191K	–	3059
2020 Q4	$191K	Buy	+25,726	New	+$133K	﹤0.01%	2211
2014 Q4	–	Sell	-13,000	Closed	-$127K	–	1589
2014 Q3	$127K	Buy	+13,000	New	+$159K	﹤0.01%	1413